AML WITH MUTATED NPM1
Clinical trials for AML WITH MUTATED NPM1 explained in plain language.
Never miss a new study
Get alerted when new AML WITH MUTATED NPM1 trials appear
Sign up with your email to follow new studies for AML WITH MUTATED NPM1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail tested for aggressive blood cancer
Disease control Recruiting nowThis early-stage study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and tolerable for patients. It focuses on adults with acute myeloid leukemia that has returned or not responded to prior therapy and has specific geneti…
Matched conditions: AML WITH MUTATED NPM1
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: AML WITH MUTATED NPM1
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC